Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 11:38AM ET
2.19
Dollar change
+0.11
Percentage change
5.29
%
Index- P/E- EPS (ttm)-0.36 Insider Own64.22% Shs Outstand25.63M Perf Week3.79%
Market Cap56.79M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.28M Perf Month-19.00%
Income-9.35M PEG- EPS next Q-0.11 Inst Own28.17% Short Float0.07% Perf Quarter-19.49%
Sales0.00M P/S- EPS this Y10.64% Inst Trans45.05% Short Ratio1.07 Perf Half Y1.86%
Book/sh0.19 P/B11.39 EPS next Y- ROA-91.51% Short Interest0.01M Perf Year-5.60%
Cash/sh0.20 P/C11.03 EPS next 5Y- ROE-104.28% 52W Range1.62 - 4.05 Perf YTD-9.50%
Dividend Est.- P/FCF- EPS past 5Y- ROI-187.50% 52W High-45.93% Beta-1.10
Dividend TTM- Quick Ratio5.32 Sales past 5Y0.00% Gross Margin- 52W Low35.19% ATR (14)0.20
Dividend Ex-Date- Current Ratio5.32 EPS Y/Y TTM22.62% Oper. Margin0.00% RSI (14)39.25 Volatility6.11% 8.53%
Employees2 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q41.58% Payout- Rel Volume0.51 Prev Close2.08
Sales Surprise- EPS Surprise48.59% Sales Q/Q- EarningsMay 15 BMO Avg Volume5.80K Price2.19
SMA20-14.14% SMA50-17.62% SMA200-15.97% Trades Volume1,182 Change5.29%
May-15-24 09:55PM
01:05PM
Feb-13-24 04:05PM
Nov-14-23 04:05PM
Oct-19-23 09:40AM
04:06PM Loading…
Oct-06-23 04:06PM
04:06PM
Oct-03-23 09:40AM
Sep-21-23 10:06AM
Sep-20-23 04:29PM
Aug-30-23 08:00AM
Aug-22-23 09:37AM
Aug-21-23 08:00AM
Aug-15-23 10:20AM
Jun-12-23 09:40AM
08:33AM Loading…
May-30-23 08:33AM
May-24-23 09:40AM
May-19-23 09:35AM
May-11-23 08:00AM
Mar-28-23 08:00AM
Mar-08-23 08:00AM
Feb-14-23 09:30AM
Feb-10-23 08:38AM
Jan-09-23 08:00AM
Dec-21-22 05:42AM
Nov-10-22 08:00AM
Nov-01-22 04:00PM
Sep-26-22 08:56AM
07:00AM
07:00AM
08:00AM Loading…
Sep-20-22 08:00AM
Sep-09-22 08:00AM
Aug-23-22 05:00PM
Aug-16-22 03:00PM
Jul-14-22 06:23AM
Jul-05-22 07:57AM
06:00AM
Jun-23-22 04:00PM
May-24-22 04:00PM
May-11-22 09:00AM
Apr-01-22 07:00AM
Feb-11-22 08:00AM
Feb-04-22 04:30AM
Jan-06-22 07:00AM
07:00AM
Jan-04-22 07:00AM
Jan-03-22 07:00AM
Nov-12-21 08:00AM
Oct-13-21 08:00AM
Oct-12-21 08:59AM
Oct-05-21 08:00AM
Sep-27-21 07:41AM
Sep-22-21 04:05PM
Sep-20-21 08:13AM
Sep-13-21 08:00AM
08:00AM
Sep-07-21 08:00AM
07:04AM
Aug-23-21 08:31AM
Aug-16-21 08:39AM
Aug-12-21 08:00AM
Aug-09-21 08:01AM
Aug-08-21 03:23AM
Aug-03-21 02:40PM
Jul-26-21 08:02AM
Jul-12-21 08:22AM
Jun-21-21 04:05PM
May-06-21 08:00PM
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, ANEB-001, is currently in phase two of trial. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.